Koroner Arter Hastalığının Saptanmasında Platformlar Arası Kan Transkriptomi Analiziyle İki Genli Bir Sınıflandırıcının Belirlenmesi
PDF
Atıf
Paylaş
Talep
Özgün Araştırma
CİLT: 14 SAYI: 2
P: 160 - 171
Haziran 2026

Koroner Arter Hastalığının Saptanmasında Platformlar Arası Kan Transkriptomi Analiziyle İki Genli Bir Sınıflandırıcının Belirlenmesi

Namik Kemal Med J 2026;14(2):160-171
Bilgi mevcut değil.
Bilgi mevcut değil
Alındığı Tarih: 08.10.2025
Kabul Tarihi: 01.02.2026
Online Tarih: 16.06.2026
Yayın Tarihi: 16.06.2026
PDF
Atıf
Paylaş
Talep

ÖZ

Amaç

Koroner arter hastalığı (KAH) küresel ölçekte önemli bir sağlık yükü olmaya devam etmektedir ve mevcut kan biyobelirteçleri erken tanı için yeterli duyarlılığa sahip değildir. Bu çalışmanın amacı, KAH ile ilişkili dolaşımdaki mRNA ve uzun kodlamayan RNA (lncRNA) biyobelirteçlerini tanımlamak ve doğrulamak, ayrıca öngörücü bir transkriptomik model geliştirmektir.

Gereç ve Yöntem

Stabil KAH hastaları ve sağlıklı kontrollerden elde edilen plazma RNA-sekanslama verileri (GSE208194) analiz edilmiş ve bulgular bağımsız bir periferik kan mikrodizi kohortunda (GSE113079) doğrulanmıştır. Diferansiyel gen ekspresyonu | |log2 kat değişimi| ≥1 ve yanlış keşif oranı <0,05 eşikleri kullanılarak değerlendirilmiştir. Gen ontolojisi ve Kyoto Genler ve Genomlar Ansiklopedisi yolakları için zenginleştirme analizleri yapılmıştır. Öngörücü model, lojistik regresyon modeli ile cezalandırılmış lojistik regresyon kullanılarak oluşturulmuş, hiperparametreler iç içe çapraz doğrulama çerçevesinde ayarlanmış ve bağımsız doğrulama kohortunda değerlendirilmiştir.

Bulgular

Toplam 182 transkript (177 mRNA, 5 lncRNA) diferansiyel olarak eksprese bulunmuş ve bunların %91’i KAH’de aşağı regüle edilmiştir. Zenginleştirme analizleri ribozomal biyogenez, sitoplazmik translasyon, mitokondriyal oksidatif fosforilasyon ve p53/NF-κB enflamatuvar yolaklarında eşgüdümlü düzensizlikleri ortaya koymuştur. Platformlar arası doğrulama 85 transkripti teyit ederek sağlam bir ekspresyon imzasına işaret etmiştir. Öngörücü model iki geni (NEUROD2 ve RPS27) seçmiş ve doğrulama kohortunda 0,820’lik harici eğri altında kalan alan değerine ulaşmıştır.

Sonuç

Kan transkriptomik profillemesi, KAH ile ilişkili, tekrarlanabilir bir gen ekspresyon imzası ortaya koymakta ve enflamasyon ile metabolik stres süreçlerini yansıtan iki genli, yalın bir sınıflandırıcının kullanılabileceğini göstermektedir. Bu bulgular, kan temelli transkriptomik biyobelirteçlerin geliştirilmesine yönelik önemli bir temel sağlamaktadır. Ancak klinik uygulamadaki değerinin ortaya konabilmesi için daha geniş ve farklı özelliklere sahip hasta popülasyonlarında doğrulanması gerekmektedir.

Anahtar Kelimeler:
Koroner arter hastalığı, transkriptom, biyobelirteçler, RNA, lojistik modeller

Kaynaklar

1
Di Cesare M, Perel P, Taylor S, Kabudula C, Bixby H, Gaziano TA, et al. The Heart of the World. Glob Heart. 2024;19:11.
2
Mensah GA, Fuster V, Murray CJL, Roth GA; Global burden of cardiovascular diseases and risks collaborators. Global burden of cardiovascular diseases and risks, 1990-2022. J Am Coll Cardiol. 2023;82:2350-473.
3
Zaman S, Wasfy JH, Kapil V, Ziaeian B, Parsonage WA, Sriswasdi S, et al. The lancet commission on rethinking coronary artery disease: moving from ischaemia to atheroma. Lancet. 2025;405:1264-312.
4
Zhang Z, Salisbury D, Sallam T. Long noncoding RNAs in Atherosclerosis: JACC review topic of the week. J Am Coll Cardiol. 2018;72:2380-90.
5
Li X, Zhang Y, Ding Z, Chen Y, Wang W. LncRNA H19: A novel biomarker in cardiovascular disease. Acta Cardiol Sin. 2024;40:172-81.
6
Rai V. Current and future role of biomarkers in the monitoring and prognosis of coronary artery disease. Future Cardiol. 2025;21:331-3.
7
McCaffrey TA, Toma I, Yang Z, Katz R, Reiner J, Mazhari R, et al. RNAseq profiling of blood from patients with coronary artery disease: signature of a T cell imbalance. J Mol Cell Cardiol Plus. 2023;4:100033.
8
Siemelink MA, Zeller T. Biomarkers of coronary artery disease: the promise of the transcriptome. Curr Cardiol Rep. 2014;16:513.
9
Elashoff MR, Wingrove JA, Beineke P, Daniels SE, Tingley WG, Rosenberg S, et al. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients. BMC Med Genomics. 2011;4:26.
10
Voora D, Coles A, Lee KL, Hoffmann U, Wingrove JA, Rhees B, et al. An age- and sex-specific gene expression score is associated with revascularization and coronary artery disease: insights from the prospective multicenter imaging study for evaluation of chest pain (PROMISE) trial. Am Heart J. 2017;184:133-40.
11
Rosenberg S, Elashoff MR, Lieu HD, Brown BO, Kraus WE, Schwartz RS, et al. Whole blood gene expression testing for coronary artery disease in nondiabetic patients: major adverse cardiovascular events and interventions in the PREDICT trial. J Cardiovasc Transl Res. 2012;5:366-74.
12
Zhang YH, Pan X, Zeng T, Chen L, Huang T, Cai YD. Identifying the RNA signatures of coronary artery disease from combined lncRNA and mRNA expression profiles. Genomics. 2020;112:4945-58.
13
Kessler T, Schunkert H. Coronary artery disease genetics enlightened by genome-wide association studies. JACC Basic Transl Sci. 2021;6:610-23.
14
Huang J, Li M, Li J, Liang B, Chen Z, Yang J, et al. LncRNA H19 rs4929984 variant is associated with coronary artery disease susceptibility in han chinese female population. Biochem Genet. 2021;59:1359-80.
15
Wang XM, Li XM, Song N, Zhai H, Gao XM, Yang YN. Long non-coding RNAs H19, MALAT1 and MIAT as potential novel biomarkers for diagnosis of acute myocardial infarction. Biomed Pharmacother. 2019;118:109208.
16
Mu J, Chen C, Ren Z, Liu F, Gu X, Sun J, et al. Multicenter validation of lncRNA and target mRNA diagnostic and prognostic biomarkers of acute ischemic stroke from peripheral blood leukocytes. J Am Heart Assoc. 2024;13:e034764.
17
Elashoff MR, Nuttall R, Beineke P, Doctolero MH, Dickson M, Johnson AM, et al. Identification of factors contributing to variability in a blood-based gene expression test. PLoS One. 2012;7:e40068.
18
Davis S, Meltzer PS. GEOquery: a bridge between the gene expression omnibus (GEO) and BioConductor. Bioinformatics. 2007;23:1846-7.
19
Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2015;4:1521.
20
Li L, Wang L, Li H, Han X, Chen S, Yang B, et al. Characterization of LncRNA expression profile and identification of novel LncRNA biomarkers to diagnose coronary artery disease. Atherosclerosis. 2018;275:359-67.
21
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.
22
Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation (Camb). 2021;2:100141.
23
Xu S, Hu E, Cai Y, Xie Z, Luo X, Zhan L, et al. Using clusterProfiler to characterize multiomics data. Nat Protoc. 2024;19:3292-320.
24
Korkmaz S, Goksuluk D, Karaismailoglu E. fastml: Guarded resampling workflows for safe and automated machine learning in R. R package version 0.7.7. 2026. Available from: https://CRAN.R-project.org/package=fastml
25
Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010;33:1-22.
26
Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011;12:77.
27
Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350:g7594.
28
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke J, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg. 2014;12:1495-9.
29
Altman DG, McShane LM, Sauerbrei W, Taube SE. Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration. PLoS Med. 2012;9:e1001216.
30
Chen Y, Yang M, Huang W, Chen W, Zhao Y, Schulte ML, et al. Mitochondrial metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses. Circ Res. 2019;125:1087-102.
31
Park S, Trujillo-Hernandez JA, Levine RL. Ndufaf2, a protein in mitochondrial complex I, interacts in vivo with methionine sulfoxide reductases. Redox Rep. 2023;28:2168635.
32
Bustamante Rivera YY, Brütting C, Schmidt C, Volkmer I, Staege MS. Endogenous retrovirus 3 - history, physiology, and pathology. Front Microbiol. 2018;8:2691.
33
Wang S, Hui Y, Li X, Jia Q. Silencing of lncRNA CCDC26 restrains the growth and migration of glioma cells in vitro and in vivo via targeting miR-203. Oncol Res. 2018;26:1143-54.
34
Ward Z, Schmeier S, Pearson J, Cameron VA, Frampton CM, Troughton RW, et al. Identifying candidate circulating RNA markers for coronary artery disease by deep RNA-sequencing in human plasma. Cells. 2022;11:3191.
35
Cao J, Yang Y, Duan B, Zhang H, Xu Q, Han J, et al. LncRNA PCED1B-AS1 mediates miR-3681-3p/MAP2K7 axis to promote metastasis, invasion and EMT in gastric cancer. Biol Direct. 2024;19:34.
36
Yuan H, Ren Q, Du Y, Ma Y, Gu L, Zhou J, et al. LncRNA miR663AHG represses the development of colon cancer in a miR663a-dependent manner. Cell Death Discov. 2023;9:220.
37
Arencibia A, Lanas F, Salazar LA. Long non-coding RNAs might regulate phenotypic switch of vascular smooth muscle cells acting as ceRNA: implications for in-Stent restenosis. Int J Mol Sci. 2022;23:3074.
38
Tan X, Yan C, Zou G, Jing R. Neurogenic differentiation 2 promotes inflammatory activation of macrophages in doxorubicin-induced myocarditis via regulating protein kinase D. BMC Cardiovasc Disord. 2025;25:195.
39
Feng J, Li Y, Wang C, Wang Y, Wan Y, Zheng M, et al. Peripheral blood transcriptomic analysis identifies potential inflammation and immune signatures for central retinal artery occlusion. Sci Rep. 2024;14:7398.
40
DeGroat W, Abdelhalim H, Peker E, Sheth N, Narayanan R, Zeeshan S, et al. Multimodal AI/ML for discovering novel biomarkers and predicting disease using multi-omics profiles of patients with cardiovascular diseases. Sci Rep. 2024;14:26503.
41
Yao Z, Zhang Q, Guo F, Guo S, Yang B, Liu B, et al. Long Noncoding RNA PCED1B-AS1 promotes the warburg effect and tumorigenesis by upregulating HIF-1α in glioblastoma. Cell Transplant. 2020;29:963689720906777.
42
Wang XB, Cui NH, Liu X, Ming L. Identification of a blood-based 12-gene signature that predicts the severity of coronary artery stenosis: an integrative approach based on gene network construction, support vector machine algorithm, and multi-cohort validation. Atherosclerosis. 2019;291:34-43.
43
Xing Y, Lin X. Transcriptome associated with single-cell analysis reveal the role of S-palmitoylation in coronary artery disease. Sci Rep. 2025;15:15144.
44
Vorperian SK, Moufarrej MN; Tabula Sapiens Consortium; Quake SR. Cell types of origin of the cell-free transcriptome. Nat Biotechnol. 2022;40:855-61.
45
Diao MQ, Li C, Xu JD, Zhao XF, Wang JX. RPS27, a sORF-encoded polypeptide, functions antivirally by activating the NF-κB pathway and interacting with viral envelope proteins in shrimp. Front Immunol. 2019;10:2763.